Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2023 (Filing Date: February 22, 2023)
Purpose: Furnishing a press release dated February 21, 2023, as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves solely to transmit a press release and does not contain audited or unaudited financial statements within the body of the document.
Material Changes
The filing does not disclose specific material changes to financial performance or operations. It references an attached press release (Exhibit 99.1) which is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no direct management commentary or outlook. It states that the information in the attached press release is furnished but not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated February 21, 2023) for the specific material event or announcement triggering this filing.
- Verify if the press release contains forward-looking statements or financial updates not present in the Form 6-K cover page.
- Confirm the legal status of the information as "furnished" rather than "filed" regarding liability under Section 18 of the Exchange Act.